CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENT
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. PORTERS FIVE FORCES ANALYSIS

3.3.1. Bargaining power of buyers
3.3.2. Bargaining power of suppliers
3.3.3. Threat of substitutes
3.3.4. Threat of new entrants
3.3.5. Competitive rivalry

3.4. TOP PLAYERS POSITIONING, 2016
3.5. MARKET DYNAMICS

3.5.1. Drivers

3.5.1.1. Increase in geriatric population and surge in incidence and prevalence of chronic diseases
3.5.1.2. Increase in government expenditure in the healthcare sector

3.5.2. Restraint

3.5.2.1. Complex regulatory framework

3.5.3. Opportunity

3.5.3.1. Lucrative opportunities from emerging economies

CHAPTER 4 IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, BY TECHNOLOGY

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. RADIOIMMUNOASSAY

4.2.1. Key market trends
4.2.2. Key growth factors and opportunities
4.2.3. Market size and forecast

4.3. IMMUNOTURBIDITY ASSAY

4.3.1. Key market trends
4.3.2. Key growth factors and opportunities
4.3.3. Market size and forecast

4.4. CHEMILUMINESCENCE ASSAY

4.4.1. Key market trends
4.4.2. Key growth factors and opportunities
4.4.3. Market size and forecast

4.5. IMMUNOPROTEIN ELECTROPHORESIS

4.5.1. Key market trends
4.5.2. Key growth factors and opportunities
4.5.3. Market size and forecast

4.6. ENZYME-BASED IMMUNOASSAY

4.6.1. Key market trends
4.6.2. Key growth factors and opportunities
4.6.3. Market size and forecast

4.7. IMMUNOFLUORESCENCE ASSAY

4.7.1. Key market trends
4.7.2. Key growth factors and opportunities
4.7.3. Market size and forecast

4.8. OTHER TECHNOLOGY

4.8.1. Key market trends
4.8.2. Key growth factors and opportunities
4.8.3. Market size and forecast

CHAPTER 5 IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, BY TYPE

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. C-REACTIVE PROTEIN DIAGNOSTIC TEST

5.2.1. Market size and forecast

5.3. COMPLEMENT SYSTEM PROTEIN DIAGNOSTIC TEST

5.3.1. Market size and forecast

5.4. PREALBUMIN DIAGNOSTIC TEST

5.4.1. Market size and forecast

5.5. HAPTOGLOBIN DIAGNOSTIC TEST

5.5.1. Market size and forecast

5.6. IMMUNOGLOBULIN DIAGNOSTIC TEST

5.6.1. Market size and forecast

5.7. FREE LIGHT CHAIN DIAGNOSTIC TEST

5.7.1. Market size and forecast

5.8. OTHER IMMUNOPROTEIN DIAGNOSTIC TEST

5.8.1. Market size and forecast

CHAPTER 6 IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, BY APPLICATION

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. AUTOIMMUNE TESTING

6.2.1. Market size and forecast

6.3. INFECTIOUS DISEASE TESTING

6.3.1. Market size and forecast

6.4. ALLERGY TESTING

6.4.1. Market size and forecast

6.5. ENDOCRINE DISEASE TESTING

6.5.1. Market size and forecast

6.6. ONCOLOGY TESTING

6.6.1. Market size and forecast

6.7. TOXICOLOGY TESTING

6.7.1. Market size and forecast

6.8. OTHERS

6.8.1. Market size and forecast

CHAPTER 7 IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, BY GEOGRAPHY

7.1. OVERVIEW

7.1.1. Market size and forecast

7.2. NORTH AMERICA

7.2.1. Key market trends
7.2.2. Key growth factors and opportunities
7.2.3. Market size and forecast
7.2.4. U.S. market size and forecast
7.2.5. Canada market size and forecast
7.2.6. Mexico market size and forecast

7.3. EUROPE

7.3.1. Key market trends
7.3.2. Key growth factors and opportunities
7.3.3. Market size and forecast
7.3.4. Germany market size and forecast
7.3.5. France market size and forecast
7.3.6. UK market size and forecast
7.3.7. Italy market size and forecast
7.3.8. Spain market size and forecast
7.3.9. Rest of Europe market size and forecast

7.4. ASIA-PACIFIC

7.4.1. Key market trends
7.4.2. Key growth factors and opportunities
7.4.3. Market size and forecast
7.4.4. Japan market size and forecast
7.4.5. China market size and forecast
7.4.6. India market size and forecast
7.4.7. Rest of Asia-Pacific market size and forecast

7.5. LAMEA

7.5.1. Key market trends
7.5.2. Key growth factors and opportunities
7.5.3. Market size and forecast
7.5.4. Latin America market size and forecast
7.5.5. Middle East market size and forecast
7.5.6. Africa market size and forecast

CHAPTER 8 COMPANY PROFILES

8.1. ABBOTT LABORATORIES

8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.1.6. Key strategic moves and developments

8.2. ABCAM PLC

8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Business performance
8.2.6. Key strategic moves and developments

8.3. BIO-RAD LABORATORIES, INC.

8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance
8.3.6. Key strategic moves and developments

8.4. DANAHER CORPORATION

8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segment
8.4.4. Product portfolio
8.4.5. Business performance

8.5. DIASORIN S.P.A

8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.5.6. Key strategic moves and developments

8.6. ENZO BIOCHEM, INC.

8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Operating business segments
8.6.5. Business performance
8.6.6. Key strategic moves and developments

8.7. F. HOFFMANN-LA ROCHE AG (ROCHE DIAGNOSTICS)

8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance
8.7.6. Key strategic moves and developments

8.8. ORTHO CLINICAL DIAGNOSTICS

8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Key strategic moves and developments

8.9. SIEMENS AKTIENGESELLSCHAFT

8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating segments
8.9.4. Product portfolio
8.9.5. Business performance

8.10. THERMO FISHER SCIENTIFIC INC

8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance